CMPX- Compass Therapeutics, Inc.

Name: Compass Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Compass Therapeutics, Inc. (CMPX) has 12 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. CMPX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Schuetz Thomas J.	6.60M	$13.34M	-
Other	Sirard Cynthia	1.00M	$2.02M	-
Other	Prasad Arjun	1.00M	$2.02M	-
CFO	Shin Barry	525.0K	$1.06M	-
Other	Lerner Neil	397.5K	$803.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 13, 2022	Orbimed Advisors LLC67	Director, 10% Owner	Buy	192,516	$2.18	$420,481.68	+0.4%	+8.3%	+28.1%
May 10, 2022	Schuetz Thomas J.66	Chief Executive Officer	Buy	27,836	$1.80	$50,104.80	+0.5%	+58.5%	+105.5%
May 10, 2022	Gordon Carl L74	Director, 10% Owner	Buy	125,359	$1.57	$197,251.92	+0.3%	+58.5%	+105.5%
May 10, 2022	Orbimed Advisors LLC67	Director, 10% Owner	Buy	125,359	$1.57	$197,251.92	+0.3%	+58.5%	+105.5%
Nov 4, 2021	Orbimed Advisors LLC67	Director, 10% Owner	Buy	5,357,143	$3.50	$18,750,000.50	+42.1%	-55.7%	+14.3%
Nov 4, 2021	Gordon Carl L74	Director, 10% Owner	Buy	5,357,143	$3.50	$18,750,000.50	+42.1%	-55.7%	+14.3%
Jun 19, 2020	Orbimed Advisors LLC67	Director, 10% Owner	Buy	1,455,132	$5.00	$7,275,660.00	+12.9%	-	-
Jun 19, 2020	Ferneau Philip	Director	Buy	314,066	$5.00	$1,570,330.00	+12.9%	-	-
Jun 19, 2020	Schuetz Thomas J.66	Chief Executive Officer	Buy	97,431	$5.00	$487,155.00	+2.2%	-	-
Jun 19, 2020	Gordon Carl L74	Director, 10% Owner	Buy	1,455,132	$5.00	$7,275,660.00	+12.9%	-	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC